Targeted Matrix-Modulating Enzymes
For enhanced monoclonal antibody uptake and distribution in solid tumors
Published: 15th September 2022

Patents
- U.S. Patent Application No. 17/638,725, filed 25 February 2022
IP Status
- Patent application submitted
Seeking
- Licensing